Research
ELRIG Research & Innovation 2024
This event will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more pat...
Optibrium enables collaborative design in its StarDrop platform
The new Idea Tracker capability further improves the efficiency of drug discovery by supporting project management, idea sharing and molecule design tracking The software promotes collaboration within and across teams for more cohesive workflows ...
Functional genomics and AI: super sleuths in the search for new therapies
Find out more about functional genomics and why AI (artificial intelligence) is key to its interpretation. ...
ELRIG UK announces Steve Bates and Dr Anderson Ryan as Keynote Speakers at Research and Innovation 2024
ELRIG Research and Innovation 2024 takes place from 20–21 March in Manchester, UK Key topics include oncology, antimicrobial resistance, mass spectrometry, proteomics and animal-free drug discovery Launch of TechBio Breakthrough Zone offers young companies an opportunity to showcas...
Target to Patient: Creating tomorrow’s drug discovery toolbox
This meeting will focus on ground-breaking advances in genomics for target choice, in vitro technologies, novel modalities, risk mitigation, data analysis, AI/ML, digital health, and how they could radically increase the discovery of disease relevant biological targets and the developme...
Design studio Apropos- helps climate group Architects Declare prepare for a busy year
Architects Declare is a network of architectural practices committed to addressing the climate and biodiversity emergency. We are helping the group refine their identity and have produced a new logotypes, print and digital communications and a comprehensive design guidelines document. ...
Ag101 - An Introduction to the Industry
Ag101 is a soft-landing introduction for professionals wanting to learn more about the agriculture and horticulture industry. This whole-day event will help you to understand the challenges and needs of this dynamic space, the opportunities that technology can offer it, and how to get i...
Maxion Therapeutics welcomes Dr Arndt Schottelius as new CEO
Maxion Therapeutics, the biotechnology company developing antibody-based drugs for previously untreatable ion channel- and GPCR-driven diseases, announces that Dr Arndt Schottelius has been appointed as the new Chief Executive Officer, effective on 1 March 2024, to take the Company to i...
Celebrating International Women’s Day at Cambridge Judge
Join The Wo+Men’s Leadership Centre at Cambridge Judge Business School on 8 March 2024 as we celebrate International Women’s Day. The evening offers an exciting schedule of talks, panel discussions and our third Professor Sucheta Nadkarni Research Seminar. ...
Queensgate awarded funding for fourth research project with NPL
Queensgate, a brand of Prior Scientific, has won funding from Innovate UK, the UK’s innovation agency, for a fourth nanopositioning research project as part of Analysis for Innovators (A4I) program (Round 11). ...